TYLER, Texas, May 17, 2006 (PRIMEZONE) -- Biogenerics Limited (Pink Sheets:BIGN) announced today that its head office in Tyler, Texas is up and running and now fully operational. The company also stated that newly appointed Director Mr. James Lancaster is currently, with due diligence, evaluating several projects in the oil and gas sector. Pertinent information regarding these projects will be passed on as soon as it is made available.
Biogenerics Limited, because of previous delays, also confirms that the record date of May 19, 2006 for the Tyche Special Dividend is on schedule and will follow with the payment date of June 2, 2006 as mentioned in the May 3, 2006 press release.
About Biogenerics Limited:
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics has oil and gas assets acquired from Rubicon Petroleum. The company also has joint venture activities with Tyche Energy and Hydroslotter Corporation.
About Hydroslotter Corporation:
Hydroslotter Corporation's proprietary technology deemed "hydroslotting" increases oil and gas production and extends commercial productivity of oil and gas by 300% to 600%. Hydroslotter's technology is cost effective and for the inexpensive cost of the actual re-work on potential shut-in wells, the return on investment is high.
Website: http://www.bignltd.com
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.